Early-Phase Pharmaceutical Manufacturing Services

Luina Bio is a Brisbane, Australia-based contract development and manufacturing organization (CDMO) that provides microbial biomanufacturing to the pharmaceutical, biotechnology, and veterinary industries.

For more than 20 years, Luina Bio has been a world leader in microbial biomanufacturing, specializing in recombinant proteins and vaccines and complex live therapeutic products.

Luina Bio’s Path to Success

Previously known as PharmaSynth, Luina Bio was part of Progen Pharmaceuticals Ltd beginning in 1990. The CMO division provided microbial fermentation services to many local and international clients, building years of expertise and experience. PharmaSynth was established in 2008, separating from Progen Pharmaceuticals to enable standalone operations and visibility to the biotechnology market.

In 2016, PharmaSynth Pty Ltd was bought by Luina Group Pty Ltd in a management/investor buyout and the company was renamed Luina Bio Pty Ltd.

Today, Luina Bio Pty Ltd is one of Australia’s most experienced biopharmaceutical CDMOs, offering trusted, client-focused services to both domestic and international clients.


Australia’s Pharmaceutical Manufacturing Services Advantage

World-class researchers and proven facilities, a streamlined regulatory framework, generous tax incentives, and government funding make Australia a prime location for biotech research. To learn more, download our overview.